Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

RAIN Rain Oncology Inc

1.21

0.00 (0.00%)

After Hours

Last Updated: 20:00:00

Delayed by 15 minutes

Rain Therapeutics initiates late-stage milademetan cancer trial

To read the full story on Seeking Alpha, click here.

Rain Oncology (NASDAQ:RAIN)
Historical Stock Chart
From Mar 2024 to Apr 2024

Click Here for more Rain Oncology Charts.

Rain Oncology (NASDAQ:RAIN)
Historical Stock Chart
From Apr 2023 to Apr 2024

Click Here for more Rain Oncology Charts.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Share on Facebook Share on Twitter Share on Email

Loading Messages....

See More Message Board Posts

Rain Therapeutics Inc News

More Rain Therapeutics Inc News Articles

Canopus Biopharma (PK)

Nexus Energy Services (PK)

FuelCell Energy

Federal Home Loan Mortgage (QB)

Bell Buckle (PK)

Therapeutic Solutions (PK)

Impact Fusion (PK)

Strategic Asset Leasing (PK)

Anavex Life Sciences

GNCC Capital (CE)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions